These studies highlight the differential yet indispensable roles of AKT1 and AKT2 in PTEN-deficient cancer development, suggesting that AKT1 may drive the initial establishment of solid tumours whereas AKT2 may be intrinsic to tumour maintenance and survival. The gene discussed is PTEN; the disease is cancer.